In a new study led by the National Cancer Institute, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment with immune checkpoint inhibitors, a novel type of immunotherapy. The study was published August 20, 2018 in Nature Medicine.
To read more about this study, click here.
No comments:
Post a Comment